Skip to main content
Premium Trial:

Request an Annual Quote

Maxygen To Consult With Swedish Bioinformatics Firm Prevas

NEW YORK, April 23-The Swedish bioinformatics firm Prevas Bioinformatics will be working with Maxygen to improve information systems, streamline discovery and identify bottlenecks, Prevas said in a statement yesterday.

 

As part of its feasibility study, the company will analyze the manual routines and databases that Maxygen uses to characterize leads and suggest new custom software and lab information systems to improve performance.

Prevas is an IT consultancy company based in Stockholm. It specializes in bioinformatics, industry and telecoms.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.